Abstract
e17561Background: to evaluate the activity and mechanism of rAd-p53 combined with chemotherapeutics in treatment of ATC in vitro and in vivoand clinical therapies. Methods: p53-mutant ATC cells (C6...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have